Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is NOT a side effect of atropine?

Diarrhoea. ***Diarrhoea*** - Atropine is a **muscarinic antagonist** that blocks the action of **acetylcholine** on muscarinic receptors in the gastrointestinal tract. - This leads to **decreased GI motility** and **decreased secretions**, typically causing **constipation**, NOT diarrhoea. - Diarrhoea would be associated with **cholinergic agonists** or anticholinesterases, which increase GI motility. *Blurring of vision* - Atropine causes **mydriasis** (pupil dilation) and **cycloplegia** (paralysis of the ciliary muscle). - **Cycloplegia** impairs accommodation for near vision, leading to **blurring of vision**. - This is a common anticholinergic side effect. *Urinary retention* - Atropine blocks **M3 receptors** on the **detrusor muscle**, causing bladder relaxation and reduced contractility. - This leads to **urinary retention**, especially in patients with pre-existing conditions like **prostatic hypertrophy**. *Confusion in elderly* - Atropine can cross the **blood-brain barrier** and cause **CNS effects** including confusion, agitation, and delirium. - Elderly patients are particularly susceptible to these **central anticholinergic effects**.

Q: Propranolol is most commonly prescribed as first-line therapy for which condition?

Thyrotoxicosis (excessive thyroid hormones). ***Thyrotoxicosis (excessive thyroid hormones)*** - **Propranolol** is commonly prescribed as **first-line symptomatic therapy** for **thyrotoxicosis** to manage symptoms such as **tachycardia, tremors, palpitations, and anxiety**. - It works by **blocking peripheral conversion of T4 to T3** and providing rapid **symptomatic relief** through beta-blockade. - While it does not treat the underlying thyroid disorder, it is the **immediate first-line agent** for symptom control while definitive treatment (antithyroid drugs, radioiodine, or surgery) is being arranged. - **Clinical pearl:** Propranolol is preferred over selective beta-blockers due to its additional effect on T4 to T3 conversion. *Hypertension (high blood pressure)* - **Propranolol** is **NOT a first-line agent** for hypertension in current guidelines (JNC 8, ESC/ESH). - First-line agents include **ACE inhibitors, ARBs, thiazide diuretics, and calcium channel blockers**. - Non-selective beta-blockers like propranolol are typically **third-line or later** due to unfavorable metabolic effects and side effect profile. - Selective beta-blockers (atenolol, metoprolol) may be used in specific hypertension scenarios, but propranolol is rarely first-line. *Atrioventricular (AV) block* - **Propranolol** is **absolutely contraindicated** in **AV block** as it further slows conduction through the AV node. - Beta-blockers can precipitate **complete heart block** in patients with pre-existing conduction abnormalities. *Cardiac arrest* - **Propranolol** is **contraindicated** in acute management of **cardiac arrest** as it reduces cardiac contractility and can worsen outcomes. - Cardiac arrest management involves **CPR, defibrillation, epinephrine, and amiodarone**.

Q: Which of the following is not a common side effect of clonidine?

Diarrhea. ***Diarrhea*** - **Clonidine** commonly causes **constipation**, not diarrhea, due to its **alpha-2 adrenergic agonist** effects, which decrease gastrointestinal motility. - Diarrhea is not typically associated with clonidine's mechanism of action or adverse effect profile. *Xerostomia* - **Xerostomia** (dry mouth) is a very common side effect of **clonidine** occurring in up to 40% of patients. - This results from **alpha-2 agonist** activity that reduces sympathetic stimulation of salivary gland secretions. - This symptom can significantly impact patient compliance and quality of life. *Sedation* - **Sedation** is a frequent side effect of **clonidine**, particularly when initiating treatment or increasing dosage, because it acts as an **alpha-2 agonist** in the central nervous system, reducing sympathetic outflow and promoting drowsiness. - Patients are often advised to avoid driving or operating heavy machinery until they know how the medication affects them. *Impotency* - **Impotency** or **erectile dysfunction** is a recognized and common sexual side effect of **clonidine**, which can interfere with quality of life and adherence to treatment for hypertension. - This effect is related to the drug's impact on the autonomic nervous system and vascular tone through central alpha-2 agonism.

Q: What is the half-life of nicotine in blood?

2 hours. ***2 hours*** - Nicotine has a **relatively short half-life** in the blood, typically around 2 hours, contributing to frequent dosing in tobacco users. - This rapid elimination means that nicotine concentrations decrease significantly within a few hours after the last dose, leading to **withdrawal symptoms** or cravings. *15 minutes* - A 15-minute half-life would imply an **extremely rapid clearance**, which is not characteristic of nicotine. - Such quick elimination would make it very difficult to maintain consistent drug levels and would lead to immediate, intense withdrawal. *5 hours* - While longer than the actual half-life, 5 hours is still within the realm of substances requiring **multiple daily doses**. - However, it would mean nicotine levels would remain elevated for a longer period than observed, potentially delaying withdrawal. *24 hours* - A 24-hour half-life would mean nicotine would accumulate significantly in the body with daily use, leading to **prolonged effects** and a much slower decline in concentrations after cessation. - This half-life is typical for drugs designed for **once-daily dosing**, which is not the case for nicotine.

Q: Which is the longest acting anti-cholinesterase?

Echothiophate. ***Echothiophate*** - **Echothiophate** is an **organophosphate** compound that irreversibly inhibits acetylcholinesterase, leading to a prolonged duration of action, often measured in weeks. - Due to its **long-acting** and irreversible nature, it is primarily used in ophthalmic preparations for glaucoma but is not commonly used systemically. *Pyridostigmine* - **Pyridostigmine** is a medium-acting anticholinesterase, typically lasting **3-6 hours**, and is commonly used for the chronic management of **myasthenia gravis**. - Its effects are **reversible**, binding to the enzyme for a limited period. *Ambenonium* - **Ambenonium** has a longer duration of action than pyridostigmine, typically lasting **4-8 hours**, but is still considered a reversible inhibitor. - It was historically used for **myasthenia gravis** but is now less common due to the availability of other effective treatments. *Edrophonium* - **Edrophonium** is a very short-acting anticholinesterase, with effects lasting only **5-15 minutes**, making it ideal for the **Tensilon test** to diagnose myasthenia gravis and differentiate between myasthenic and cholinergic crises. - Its rapid onset and brief duration are due to its **reversible** and transient binding to acetylcholinesterase.

Q: Which of the following is a lipid insoluble beta-blocker?

Celiprolol. ***Celiprolol*** - **Celiprolol** is a **hydrophilic** (lipid-insoluble) beta-blocker, meaning it has low lipid solubility and does not readily cross the blood-brain barrier. - This property reduces the likelihood of **CNS side effects** such as nightmares and insomnia. *Timolol* - **Timolol** is a **lipophilic** (lipid-soluble) beta-blocker, allowing it to penetrate the central nervous system. - Its high lipid solubility contributes to a higher incidence of **CNS side effects**. *Carvedilol* - **Carvedilol** is a **lipophilic** mixed alpha and beta-blocker, which means it can cross the blood-brain barrier. - This can lead to central nervous system effects, although its primary clinical use is in heart failure and hypertension. *Pindolol* - **Pindolol** is a **lipophilic** beta-blocker with intrinsic sympathomimetic activity (ISA). - Its lipid solubility allows it to enter the brain, potentially causing **CNS-related side effects**.

Q: Beta2-agonists cause all except:

Hyperkalemia. ***Hyperkalemia*** - Beta2-agonists actually cause **hypokalemia**, not hyperkalemia, by promoting the intracellular shift of potassium. - This effect is due to the stimulation of the **Na+/K+-ATPase pump** by beta-2 adrenergic receptors. *Hyperglycemia* - Beta2-agonists can lead to **hyperglycemia** by promoting glycogenolysis and gluconeogenesis in the liver. - They also decrease **insulin secretion** and increase insulin resistance. *Tremor* - **Tremor** is a common side effect of beta2-agonists, particularly in the hands, due to direct stimulation of beta2 receptors on skeletal muscle. - This muscle stimulation leads to increased muscle twitching and a fine tremor. *Palpitation* - **Palpitations** can occur due to the systemic absorption of beta2-agonists, leading to activation of beta1 receptors in the heart. - This can cause **tachycardia** and a sensation of a racing heart.

Q: Which class of drugs does botulinum toxin mimic in its action?

Anticholinergics. ***Anticholinergics*** - **Botulinum toxin** inhibits the release of **acetylcholine** from **presynaptic nerve terminals** [2] by preventing vesicle fusion, leading to muscle paralysis [1]. - While the **mechanism differs** (botulinum acts presynaptically, anticholinergics act postsynaptically at receptors), the **functional outcome** is similar: reduced cholinergic neurotransmission. - In terms of **clinical effect** at the neuromuscular junction, both reduce acetylcholine's action, making anticholinergics the closest functional parallel among the given options. *Cholinergics* - **Cholinergics** enhance acetylcholine activity, either by increasing its release, mimicking its effects at receptors, or inhibiting its breakdown. - This is the **opposite** of botulinum toxin's action, which reduces acetylcholine's impact. *Adrenergics* - **Adrenergics** stimulate the **sympathetic nervous system** via **adrenergic receptors** (α and β receptors). - They act on **norepinephrine/epinephrine pathways**, not the cholinergic system where botulinum toxin acts. *Antiadrenergic* - **Antiadrenergic drugs** block **adrenergic receptors** or inhibit sympathetic activity. - These are unrelated to botulinum toxin's effect on **cholinergic neuromuscular transmission**.

Q: Which of the following is a benzylisoquinoline muscle relaxant?

Doxacurium. ***Doxacurium*** - **Doxacurium** is a long-acting, non-depolarizing neuromuscular blocker classified as a **benzylisoquinoline** compound [1]. - These agents are known for their minimal cardiovascular effects and lack of histamine release in therapeutic doses [1]. *Vecuronium* - **Vecuronium** is an **aminosteroid** non-depolarizing neuromuscular blocker [2]. - It is known for its intermediate duration of action and minimal cardiovascular effects [1]. *Rocuronium* - **Rocuronium** is also an **aminosteroid** non-depolarizing neuromuscular blocker [2]. - It has a rapid onset of action, making it suitable for rapid sequence intubation, and can be reversed by **sugammadex**. *Pancuronium* - **Pancuronium** is an **aminosteroid** non-depolarizing neuromuscular blocker with a long duration of action [1]. - It is associated with a vagolytic effect that can cause an increase in **heart rate** and **blood pressure** [1].

Q: Botulinum toxin acts on

Synapse. ***Synapse*** - **Botulinum toxin** acts by inhibiting the release of **acetylcholine** at the **neuromuscular junction**, which is a type of synapse. - This blockade of neurotransmitter release at the **presynaptic terminal** prevents muscle contraction, leading to paralysis. *Smooth muscle of intestine* - While botulinum toxin can affect smooth muscle indirectly by paralyzing the motor nerves innervating them, its primary site of action is the **synapse** itself, not directly on the muscle fibers. - The toxin primarily targets the nerve endings, rather than the mechanical contractility of the muscle cell. *Central nervous system* - **Botulinum toxin** does not readily cross the **blood-brain barrier**, meaning its primary effects are peripheral. - Its therapeutic and toxic effects are localized to the **peripheral nervous system** and neuromuscular junctions. *Sensory nerves* - **Botulinum toxin** specifically targets **motor nerve endings** to inhibit acetylcholine release, leading to muscle paralysis. - It does not directly affect the function of **sensory nerve transmission** or pain perception in the same way.

Question 1

Which of the following is NOT a side effect of atropine?

Accepted Answer

Diarrhoea

Answer

Urinary retention

Answer

Confusion of elderly

Answer

Blurring of vision

Question 2

Propranolol is most commonly prescribed as first-line therapy for which condition?

Accepted Answer

Thyrotoxicosis (excessive thyroid hormones)

Answer

Atrioventricular (AV) block

Answer

Hypertension (high blood pressure)

Answer

Cardiac arrest

Question 3

Which of the following is not a common side effect of clonidine?

Accepted Answer

Diarrhea

Answer

Xerostomia

Answer

Sedation

Answer

Impotency

Question 4

What is the half-life of nicotine in blood?

Accepted Answer

2 hours

Answer

15 minutes

Answer

5 hours

Answer

24 hours

Question 5

Which is the longest acting anti-cholinesterase?

Accepted Answer

Echothiophate

Answer

Pyridostigmine

Answer

Ambenonium

Answer

Edrophonium

Question 6

Which of the following is a lipid insoluble beta-blocker?

Accepted Answer

Celiprolol

Answer

Timolol

Answer

Carvedilol

Answer

Pindolol

Question 7

Beta2-agonists cause all except:

Accepted Answer

Hyperkalemia

Answer

Hyperglycemia

Answer

Tremor

Answer

Palpitation

Question 8

Which class of drugs does botulinum toxin mimic in its action?

Accepted Answer

Anticholinergics

Answer

Adrenergics

Answer

Antiadrenergic

Answer

Cholinergics

Question 9

Which of the following is a benzylisoquinoline muscle relaxant?

Accepted Answer

Doxacurium

Answer

Rocuronium

Answer

Pancuronium

Answer

Vecuronium

Question 10

Botulinum toxin acts on

Accepted Answer

Synapse

Answer

Smooth muscle of intestine

Answer

Central nervous system

Answer

Sensory nerves

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?